(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 3.39% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Thermo Fisher Scientific's revenue in 2024 is $42,857,000,000.On average, 9 Wall Street analysts forecast TMO's revenue for 2024 to be $16,293,714,582,306, with the lowest TMO revenue forecast at $16,149,477,115,938, and the highest TMO revenue forecast at $16,412,823,951,524. On average, 9 Wall Street analysts forecast TMO's revenue for 2025 to be $17,386,237,527,962, with the lowest TMO revenue forecast at $17,130,453,639,900, and the highest TMO revenue forecast at $17,569,725,372,636.
In 2026, TMO is forecast to generate $18,779,199,078,762 in revenue, with the lowest revenue forecast at $18,715,176,367,652 and the highest revenue forecast at $18,917,873,961,763.